Blue Jay Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Blue Jay Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-200,000	Closed	-$10.9M	–	22
2017 Q1	$10.9M	Buy	200,000 +30,000	+18%	+$1.65M	5.35%	6
2016 Q4	$9.94M	Buy	+170,000	New	+$9.29M	6%	13
2016 Q1	–	Sell	-164,518	Closed	-$11.3M	–	19
2015 Q4	$11.3M	Buy	+164,518	New	+$10.9M	3.81%	14

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Blue Jay Capital Management's BMY Position: Q2 2017 in Review

Blue Jay Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2017, closing a stake of 200,000 shares — an estimated $10.9M sold.

Blue Jay Capital Management first reported a position in BMY in Q4 2015 and held it in 3 quarters. The position peaked at $11.3M in Q4 2015. 1,594 funds tracked by Wall St. Rank hold BMY as of Q2 2017.

Blue Jay Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2017 after selling out during the quarter.
Blue Jay Capital Management sold 200,000 Bristol-Myers Squibb shares in Q2 2017, an estimated $10.9M.
Blue Jay Capital Management first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 3 quarters.
Blue Jay Capital Management's Bristol-Myers Squibb position peaked at $11.3M in Q4 2015.
1,594 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.

Based on Blue Jay Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.